Working together for the family: determination of HER oncogene co-amplifications in breast cancer

HER2 is a well-studied tyrosine kinase (TK) membrane receptor which functions as a therapeutic target in invasive ductal breast carcinomas (IDC). The standard of care for the treatment of HER2-positive breast is the antibody trastuzumab. Despite specific treatment unfortunately, 20% of primary and 7...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncotarget
Glavni autori: Laurito, Sergio, Branham, María Teresita, Campoy, Emanuel, Real, Sebastián, Cueto, Juan, Urrutia, Guillermo, Gago, Francisco, Tello, Olga, Glatstein, Telma, De la Iglesia, Paola, Atanesyan, Lilit, Savola, Suvi, Roqué, Maria
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2020
Teme:
Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7367656/
https://ncbi.nlm.nih.gov/pubmed/32733648
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.27671
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items